Press release
IDT’s newsletter provides an insight into the therapeutic use of RNAi
Decoded issue 2 – Featuring an interview with Dr John RossiIntegrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has released the second issue of its educational and informative newsletter, Decoded. Available to download for free, the second issue of this quarterly newsletter includes a wealth of scientific content, and features an interview with Dr John Rossi (Department of Molecular and Cellular Biology and Beckman Research Institute of City of Hope (Duarte, CA)). With a focus on the biology and applications of eukaryotic small RNAs and their therapeutic use in HIV/AIDS and cancer, Dr Rossi’s research provides an insight into the field of RNA interference (RNAi) and its potential uses.
In his work Dr Rossi used IDT’s DsiRNA to target genes for silencing: “HIV puts its envelope out to the surface of a cell as part of the packaging process when it infects a cell. The envelope is present on the cell membrane before the virus assembles, so we thought that it could act as a receptor and the Dicer-substrate siRNA (DsiRNA) might get internalised via pinocytosis. We developed our own aptamer which was internalised nicely and, when we tagged it with a DsiRNA, we got good delivery, processing of the siRNA in cells, and target knockdown.”
To benefit from all of this and more on a regular basis, sign up to receive each quarterly issue of Decoded in print or electronically at www.idtdna.com/decoded.
Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.
Integrated DNA Technologies
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
productinfo@idtdna.com
www.idtdna.com
Alto Marketing
Office 3 | Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL
IDT enquiries
Integrated DNA Technologies
Lynette Brown – Advertising and Product Manager
t: +1 319-665-7208 e: lbrown@idtdna.com
Media enquiries
Alto Marketing Limited
Carolyn Butchers – Account Executive
t: +44 (0)1489 557672 e:carolynb@alto-marketing.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release IDT’s newsletter provides an insight into the therapeutic use of RNAi here
News-ID: 188626 • Views: …
More Releases from Integrated DNA Technologies
Troubleshooting and Optimizing Mutagenesis
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides in-depth protocols and troubleshooting suggestions for your mutagenesis applications. As part of the new, free-to-download IDT Mutagenesis Applications Guide, an extensive troubleshooting section makes it possible to optimize your mutagenesis experiments for the best possible resulting data. Everything from primer design, reaction setup, ligation and transformation efficiency, to specific reaction components and PCR parameters, are covered. The guide provides…
IDT DsiRNAs Used to Map Pain Pathways in the CNS
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, distributes the highly informative newsletter, DECODED. In this quarter’s edition the work carried out by Dr Philippe Sarret and colleagues is discussed in detail. Sarret’s laboratory is based at the Université de Sherbrooke (Quebec, Canada), where researchers are investigating novel ways to develop analgesics and are the first to attempt RNA interference (RNAi) via direct in vivo targeting of genes…
The IDT OligoCard for quick and simple ordering
Pre-payment card simplifies the oligonucleotide purchase process
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, makes it easy to purchase high quality oligonucleotides using its pre-pay OligoCard system. Credit can be easily transferred to an OligoCard using just a single PO or credit card transaction, minimizing paperwork. Oligos can then be ordered immediately, eliminating the delays associated with purchase authorization, maximizing efficiency. Transaction history is available online around the…
IDT offers pre-designed and custom assays, primers and probes for qPCR
Providing advanced algorithms to optimize any amplification
Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides a broad range of custom qPCR assays, primers, and probes. PrimeTime® qPCR Assays are available in three different sizes (Mini, Standard, and XL) and provide the forward and reverse primers, as well as a hydrolysis probe in a single tube. Primers and probes are also available separately, including the new Double-Quenched Probe™ which…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…